Swiss National Bank
PRAH

Swiss National Bank’s PRA Health Sciences, Inc. PRAH Stock Holding History

Swiss National Bank’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-142,258
Closed -$23.5M – 2642
2021
Q2 		$23.5M Sell
142,258
-4,300
-3% -$718K 0.01% 656
2021
Q1 		$22.5M Buy
146,558
+1,900
+1% +$258K 0.02% 661
2020
Q4 		$18.1M Buy
144,658
+500
+0.3% +$55.9K 0.01% 679
2020
Q3 		$14.6M Buy
144,158
+2,200
+2% +$224K 0.01% 678
2020
Q2 		$13.8M Buy
141,958
+19,300
+16% +$1.8M 0.01% 664
2020
Q1 		$10.2M Buy
122,658
+2,800
+2% +$273K 0.01% 667
2019
Q4 		$13.3M Buy
119,858
+2,100
+2% +$216K 0.01% 675
2019
Q3 		$11.7M Buy
117,758
+8,000
+7% +$794K 0.01% 711
2019
Q2 		$10.9M Buy
109,758
+3,100
+3% +$296K 0.01% 735
2019
Q1 		$11.8M Buy
106,658
+4,200
+4% +$439K 0.01% 697
2018
Q4 		$9.42M Buy
102,458
+1,900
+2% +$192K 0.01% 700
2018
Q3 		$11.1M Buy
100,558
+12,100
+14% +$1.26M 0.01% 697
2018
Q2 		$8.26M Hold
88,458
– – 0.01% 808
2018
Q1 		$7.34M Buy
88,458
+3,100
+4% +$275K 0.01% 843
2017
Q4 		$7.77M Buy
85,358
+1,100
+1% +$91.5K 0.01% 812
2017
Q3 		$6.42M Buy
84,258
+17,400
+26% +$1.32M 0.01% 882
2017
Q2 		$5.01M Buy
66,858
+1,100
+2% +$76.3K 0.01% 994
2017
Q1 		$4.29M Buy
65,758
+1,200
+2% +$70.7K 0.01% 1070
2016
Q4 		$3.56M Buy
64,558
+10,600
+20% +$582K 0.01% 1186
2016
Q3 		$3.05M Sell
53,958
-300
-0.6% -$14.7K ﹤0.01% 1234
2016
Q2 		$2.27M Buy
54,258
+9,318
+21% +$429K ﹤0.01% 1420
2016
Q1 		$1.85M Buy
44,940
+18,840
+72% +$796K ﹤0.01% 1501
2015
Q4 		$1.18M Hold
26,100
– – ﹤0.01% 1701
2015
Q3 		$1.01M Buy
26,100
+3,800
+17% +$152K ﹤0.01% 1774
2015
Q2 		$810K Buy
+22,300
New +$705K ﹤0.01% 1930

Other funds holding PRAH

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Swiss National Bank's PRAH Position: Q3 2021 in Review

Swiss National Bank sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 142,258 shares — an estimated $23.5M sold.

Swiss National Bank first reported a position in PRAH in Q2 2015 and held it in 25 quarters. The position peaked at $23.5M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Swiss National Bank reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Swiss National Bank sold 142,258 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $23.5M.
  • Swiss National Bank first reported a position in PRA Health Sciences, Inc. in Q2 2015 and held it in 25 quarters.
  • Swiss National Bank's PRA Health Sciences, Inc. position peaked at $23.5M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Swiss National Bank's 13F filing for Q3 2021, filed 8 Nov 2021.